Arcturus Therapeutics Holdings Inc.ARCTNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -16.26% | -9.87% | -46.69% | -55.81% | -85.33% |
| Gross Profit Growth | -16.26% | -9.87% | -46.69% | -64.42% | -88.58% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1.40% | +0.85% | +0.60% | +0.47% | +1.43% |
| Weighted Average Shares Diluted Growth | +1.40% | +0.85% | +0.60% | +0.47% | +1.43% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -87.61% | -46.14% | -28.57% | -73.67% | +40.01% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -19.87% | -20.79% | -20.42% | -23.83% | -21.19% |
| Book Value per Share Growth | -14.67% | -12.19% | -11.18% | -14.64% | -12.45% |
| Debt Growth | -5.51% | +33.63% | -12.68% | -25.68% | -12.44% |
| R&D Expense Growth | +19.55% | -34.87% | -49.58% | -40.55% | -44.09% |
| SG&A Expenses Growth | -1.02% | -23.81% | -16.06% | -21.68% | +13.30% |